Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03132207
Other study ID # RC17_0138
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 1, 2017
Est. completion date March 16, 2018

Study information

Verified date April 2019
Source Nantes University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Epidemiological studies have suggested that maternal periodontitis affects the fetal-placental unit, with an increased risk of adverse pregnancy outcome. Indeed, it has been suggested that the direct or indirect action of parodontopathogenic bacteria induces an inflammatory cascade that leads to spontaneous premature labor. Also, non-treatment of caries and periodontal disease can lead to acute pain and stress. This may promote self-medication and the inappropriate use of analgesic medications, potentially harmful to the health of the fetus. As part of the prevention of complications of pregnancy associated with oral diseases, the National Agency for Accreditation and Evaluation in Health (ANAES) has set up a system that allows any pregnant woman to consult between the 4th and 7th month of pregnancy, an oral health professional to carry out a complete assessment and free care. This study aims at evaluating this device among pregnant women and healthcare professionals 4 years after its implementation. On the other hand, it will make it possible to look for a possible link between the realization of an oral prenatal follow-up and the outcome of the pregnancy.


Description:

This study will concern two populations:

- pregnant women attending hospital during pregnancy monitoring and / or being hospitalized in one of the maternity wards associated with the project,

- health professionals in charge of the follow-up of these pregnant women and their childbirth.

The study will include:

- 500 pregnant women: 300 in Nantes and 200 in Brest

- 150 health professionals.


Recruitment information / eligibility

Status Completed
Enrollment 622
Est. completion date March 16, 2018
Est. primary completion date March 16, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria for pregnant women:

Any woman who is consulting or hospitalized in a maternity unit participating in the project is eligible for the following criteria:

- a voluntary adult woman who gave oral consent

- pregnant women (2nd and 3rd trimesters) or postpartum women hospitalized at the maternity ward

- women agreeing to participate in the study

For health professionals:

- midwife, maieutician, gynecologist and obstetrician,

- have graduated from a specialty,

- agreeing to participate in the study

Exclusion Criteria for pregnant women:

- child

- person under curatorship, under guardianship, deprived of liberty,

- refuse to fill in the questionnaire,

- no understanding of oral or written French,

For health professionals:

- Not graduated

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Non interventionel study
Only one questionnaire will be done for women and professional

Locations

Country Name City State
France Brest University Hospital Brest
France Nantes University Hospital Nantes

Sponsors (2)

Lead Sponsor Collaborator
Nantes University Hospital Université de Nantes

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluate the participation rate of pregnant women in the 4th month oral consultation in Nantes and Brest. Participation (yes / no) in the oral consultation of the 4th month. This is the answer to question 10 of the patient questionnaire. 4th month of pregnancy
See also
  Status Clinical Trial Phase
Completed NCT03442582 - Afluria Pregnancy Registry
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Completed NCT04548102 - Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman N/A
Completed NCT03218956 - Protein Requirement During Lactation N/A
Completed NCT02191605 - Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy N/A
Completed NCT02223637 - Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Recruiting NCT06049953 - Maternal And Infant Antipsychotic Study
Completed NCT02577536 - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting NCT06336434 - CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy Phase 1/Phase 2
Not yet recruiting NCT04786587 - Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
Not yet recruiting NCT05412238 - Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months N/A
Not yet recruiting NCT05028387 - Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
Completed NCT02683005 - Study of Hepatitis C Treatment During Pregnancy Phase 1
Completed NCT02783170 - Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women Phase 4
Recruiting NCT02507180 - Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
Recruiting NCT02564250 - Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women N/A
Recruiting NCT02619188 - Nutritional Markers in Normal and Hyperemesis Pregnancies N/A
Completed NCT02520687 - Effects of Dietary Nitrate in Hypertensive Pregnant Women Phase 1